UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 1
(Mark One)
X | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2014
OR
□ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 333-176329
CARDIGANT MEDICAL, INC. |
(Exact name of Registrant as Specified in Its Charter) |
DELAWARE |
| 26-4731758 |
(State or other jurisdiction of incorporation or organization) |
| (I.R.S. Employer Identification No.) |
|
|
|
1500 ROSECRANS AVENUE, ST 500, MANHATTAN BEACH, CALIFORNIA |
| 90266 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (310) 421-8654
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes X No □
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes X No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one).
Large Accelerated Filer □ | Accelerated Filer □ | Non-Accelerated Filer □ | Smaller reporting company X |
|
| (Do not check if a smaller reporting company) |
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No X
As of August 01, 2014, there were 23,330,662 shares of the registrant’s common stock outstanding.
1
The Registrant is filing this Amendment No. 1 to the Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2014 (“Form 10-Q”) solely to include the required XBRL files. While the XBRL files were included in the original filing, they were excluded from the Edgar system due to an internal reference to the 2012 US GAAP taxonomy. The 2013 taxonomy is now required.
Except for the items mentioned above, this Amendment No. 1 does not amend the Registrant’s previously filed Form 10-Q.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CARDIGANT MEDICAL, INC. | |
| By: /s/ Jerett A. Creed | |
Dated: August 25, 2014 |
| Jerett A. Creed |
|
| Chief Executive Officer |
By: /s/ Jerett A. Creed | ||
Dated: August 25, 2014 | Jerett A. Creed | |
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
3